JSPR Investors Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit
Jasper Therapeutics(US:JSPR) Prnewswire·2025-09-23 04:09NEW YORK , Sept. 22, 2025 /PRNewswire/ -- Why:Â Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Jasper Therapeutics, Inc. (NASDAQ: JSPR) between November 30, 2023 and July 3, 2025, both dates inclusive (the "Class Period"). ...